Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorUniversity of Rochester

About this trial

Peanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two most common causes of food-induced anaphylaxis. The proposed research will explore the development of sensitization to these food(s) in infants based on maternal consumption or avoidance during pregnancy and breastfeeding.

Eligibility criteria

Qualifiers

English-speaking adults, 18 years or older. (Spanish speaking adults may be included after consent document is translated and Spanish speaking study representatives are available to conduct and answer questions during informed consent process and for study follow up.)

Maternal consent must be provided for infants.

Pregnant women from the time pregnancy is confirmed until 27 weeks of gestation.

no chronic inflammatory conditions that require long-term systemic immunosuppressive medications in first or second trimester

Disqualifiers

Inability or unwillingness of subject to give written informed consent or comply with study protocol.

Known history of renal/liver/cardiac insufficiency in the mother or infant.

Pregnant women with PN or egg allergy.

Pregnant women who refuse to eat PN (or peanut products) and/or eggs.

Trial design

Treatments tested in this trial

  • Consumption
  • Avoidance

Treatment groups

500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Rochester

Lead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator